All posts by imreal

Technology: Computer

Old Dominion University Celebrates 25 Years of Partnership with the Virginia Community College System

Leave a comment


https://www.prweb.com/

Dr. Casiello speaks at the VCCS conference

Although so much has changed since we first began in 1994, the goal has always been, and will continue to be, the delivery of high quality, rigorous programs that prepare our students for the future.


NORFOLK, Va. (PRWEB)

In 1994, Old Dominion University and the Virginia Community College System teamed up to make higher education accessible to more Virginians through a remote learning system that was ground-breaking at the time. Through this partnership, students could earn their associate degrees from a community college in their home communities and continue their bachelor’s degree studies with ODU without having to move or commute to ODU’s campus in Norfolk, Virginia. Classes were relayed from ODU’s main campus to the community colleges or other local learning centers via satellite, and students had access to ODU faculty at their learning site.

Twenty-five years later, the satellites are no longer in use, but the distance learning partnership is still thriving. ODUOnline has grown from just a few bachelor’s degree programs to over 100 programs, and the benefits for Virginia college students keep getting better.

“Twenty-five years of partnership with VCCS means two and a half decades of joint creation of pathways for student success along with technological and accessibility improvements and money saved for students all across Virginia,” said Andy Casiello, associate vice president for distance learning. “Although so much has changed since we first began in 1994, the goal has always been, and will continue to be, the delivery of high quality, rigorous programs that prepare our students for the future.” Casiello recently spoke at the Virginia Community College Association conference in Norfolk, Virginia.

Students find they can save money by living at home and studying at a community college for the first two years. Others work full time and attend online classes as they fit education into their busy lives. More and more Virginians, especially those who aren’t within commuting distance of a university, are taking advantage. ODU’s contribution to preparing the Virginia workforce for the flood of new jobs coming to the Commonwealth has been significant.

“Our growth has been outstanding. Both ODU and VCCS are making amazing strides to meet the needs of our changing Commonwealth,” said Casiello. “Virginia is making waves, moving up, and leading the country in so many ways. Both Old Dominion University and the Virginia Community College System are prepared to continue growing our offerings to stay on the cutting edge.”

To learn more about ODU’s academic partnerships, visit https://online.odu.edu/partners.

Old Dominion University, located in the coastal city of Norfolk, is Virginia’s entrepreneurial-minded doctoral research university and has been delivering distance-learning programs for 30 years. It offers more than 100 programs through ODUOnline in a variety of formats, allowing students to complete degree programs across the world. ODU serves more than 24,000 students annually by providing the same rigorous academics online and on-campus. Learn more about ODUOnline’s programs by visiting online.odu.edu.

Share article on social media or email:

Industry: Healthcare

Dr. Dale Spencer Spreads Gum Disease Awareness to Newton, NC

Leave a comment


Dr. Dale Spencer of Hickory Dental Care, Serving Hickory, NC

Dr. Dale Spencer Raises Awareness of Gum Disease Symptoms in Newton, NC

The mission of the practice is to serve our patients, to help them have better dental health, to feel better about themselves and to do it in a caring, safe manner. That’s pretty much what we are all about.


Newton, NC (PRWEB)

To spread awareness of the importance of gum disease treatment and prevention, Dr. Dale Spencer of Hickory Dental Care invites patients with gum disease in Newton, NC to visit his practice and learn how to improve gum health.

According to a study by the Journal of Dental Research, almost half of Americans over the age of 30 have gum disease. Gum disease typically goes unnoticed, but as it progresses, it breaks down tissues beneath the gum line and can eventually lead to tooth loss. Additionally, gum disease has been linked to systemic health conditions such as diabetes, heart disease, stroke, and premature births.

Gingivitis, the first stage of gum disease, results in red, swollen gums, bleeding gums while brushing and flossing, and chronic bad breath. As gum disease advances into periodontitis and advanced periodontitis, pockets form between the teeth and gums, gums recede, connective tissue deteriorates, and eventually, patients suffer tooth and bone loss.

An expert in gum disease and its consequences, Dr. Spencer realizes the lack of mainstream knowledge about these long-term effects. As a result, he is striving to educate Newton, NC and the surrounding areas on how to recognize gum disease and promote gum health.

“The mission of the practice is to serve our patients, to help them have better dental health, to feel better about themselves and to do it in a caring, safe manner,” Dr. Spencer explains. “That’s pretty much what we are all about.”

To help patients treat gum disease, Dr. Spencer and offers multiple treatment options depending on the severity of the gum disease. These treatments include scaling and root planing, soft tissue recontouring, gum grafting, osseous surgery, and minimally invasive laser gum therapy. His laser gum therapy targets bacteria and diseased tissue without incisions, providing less pain and faster healing time for patients. Dr. Spencer also offers sedation dentistry for patients suffering with dental anxiety.

Patients in Newton, NC with swollen and bleeding gums are encouraged to connect with Dr. Spencer by calling 828-270-7853 or visiting http://www.hickorydental.com. Other services provided at Hickory Dental Care include general dentistry, dental implants, sleep apnea treatment, and cosmetic dentistry.

About the Dentist

Hickory Dental Care offers modern, comprehensive dental care to patients in Hickory, NC, including general dentistry, dental implants, sedation treatment and cosmetic dentistry. Dr. Dale Spencer is a graduate of the University of North Carolina at Chapel Hill, a Fellow of the American Academy of Implant Dentistry and a Diplomate of the American Board of Oral Implantology/Implant Dentistry. He is trained in the latest dental technology and offers comprehensive, comfortable, and predicable treatments for patients, including implant dentistry and IV sedation. The Hickory Dental Care team is dedicated to providing exceptional care for their patients and strives to create an office environment that is welcoming, compassionate, and of the highest quality. To learn more about Dr. Spencer and the services offered at Hickory Dental Care, call 828-270-7853 or visit http://www.hickorydental.com to schedule a consultation.

Share article on social media or email:

Business: Executives

Advanced Group Names Jeffrey Wolniakowski Chief Information Officer

Leave a comment


“Jeff brings to the firm a strategic vision, hands-on team building, and leadership capabilities, as well as the technical know-how necessary to support the ongoing growth of our dynamic, global business,” said Leo Sheridan, Chief Executive Officer at Advanced Group.


CHICAGO (PRWEB)

The Advanced Group, an industry-leading diversified professional staffing, consulting, and outsourcing organization, announced the recent appointment of Jeffrey Wolniakowski as Chief Information Officer.

Mr. Wolniakowski comes to Advanced Group with twenty years of experience in business and information technology (IT) management where he has led global IT operations as well as developed and implemented innovative technical solutions for several organizations. Prior to joining Advanced Group, Mr. Wolniakowski served as Chief Information Officer of Accretive Solutions where he led the firm’s IT organization through years of significant growth and also through its eventual acquisition by global services firm Resources Global Professionals (RGP). Mr. Wolniakowski transitioned to RGP as Vice President of Global Enterprise Applications where he worked with executive teams to lead technology integration activities. He was also responsible for defining enterprise IT strategies and supporting global enterprise applications that focused on information security and innovation. Earlier in his career, Mr. Wolniakowski served as the Director of Information Technology for a global logistics company.

“We are excited to have Jeff join the executive leadership team at this pivotal time in our business,” said Leo Sheridan, Chief Executive Officer at Advanced Group. “Jeff brings to the firm a strategic vision, hands-on team building, and leadership capabilities, as well as the technical know-how necessary to support the ongoing growth of our dynamic, global business.”

Mr. Wolniakowski earned a bachelor of business administration degree from Loyola University Chicago and holds CISA, CRISC, ITIL, and PMP certifications.

About the Advanced Group

Founded in 1988, Advanced Group comprises four businesses that include Advanced Clinical, Advanced Resources, Advanced RPO, and WunderLand Group. Throughout the course of 30 years, the firm has grown from a local staffing services provider to a global provider of clinical research outsourcing, consulting, and specialized staffing services across its business units. To learn more, visit http://www.advancedgroup.com/.

Share article on social media or email:

Health

Shady Grove Fertility (SGF) New York is Expanding, Welcoming Newest Board Certified Reproductive Endocrinologist, Anate Brauer, M.D., as IVF Director

Leave a comment


https://www.prweb.com/

Anate Brauer, M.D., IVF Director

“Dr. Brauer has a great bedside manner. She is always on time and she explains each step and lays out all of the options available. She seems to really focus on individualized care and not just applying the status quo.” Dr. Brauer patient


NEW YORK (PRWEB)

Shady Grove Fertility (SGF), a practice whose latest expansion brought them to New York, announced today the newest addition of its New York medical team, Anate Brauer, M.D., IVF Director.

Dr. Brauer will join colleague Tomer Singer, M.D., M.B.A. in seeing patients at SGF’s flagship New York office located in the heart of Manhattan, starting in November 2019. Dr. Brauer will offer a full range of state-of-the-art in-house diagnostic and treatment options for female and male infertility, elective fertility preservation, fertility preservation prior to cancer treatment, third-party reproduction, and LGBTQ family building.

Dr. Brauer earned her medical degree from the George Washington University School of Medicine, where she was elected to the prestigious Alpha Omega Alpha medical honor society. She completed her residency in Obstetrics and Gynecology at New York Presbyterian Hospital-Weill Cornell Medical Center. Dr. Brauer subsequently completed her fellowship training in Reproductive Endocrinology and Infertility at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine and Infertility-Weill Cornell Medical College. Prior to joining Shady Grove Fertility, Dr. Brauer was an Assistant Clinical Professor at NYU School of Medicine.

Dr. Brauer is board certified in obstetrics and gynecology and reproductive endocrinology and infertility. She has expertise in ovulation induction, in vitro fertilization (IVF), egg freezing, pre-implantation genetic testing and third-party reproduction including donor egg, donor sperm, donor embryo, and gestational surrogacy. Dr. Brauer applies the latest clinical data, state-of-the-art technology, and extensive clinical experience to optimize pregnancy rates while minimizing patient stress with her supportive approach to care.

Dr. Brauer has published and presented at numerous national meetings on the topics of optimizing fertility treatments in patients with diminished ovarian reserve, polycystic ovarian syndrome (PCOS), or those using a gestational carrier; fertility preservation; and complementary therapies in infertility. She is especially passionate about helping young patients with cancer build families, which has led her to serve on the Advisory Board of the Young Survivors Coalition.

Dr. Brauer is a regular contributor on a variety of women’s health topics to local and national media such as Parents, Reader’s Digest, Refinery 29, Woman’s Health Magazine, Byrdie and Shape, to name a few. For Shape, she serves on their expert Brain Trust.

She is a fellow of the American Congress of Obstetrics and Gynecology and an active member of the American Society for Reproductive Medicine and the Fertility Preservation Special Interest Group.

“We’re delighted to be able to offer patients of greater New York access to Dr. Singer and now Dr. Brauer. Dr. Brauer offers her patients the very best in personalized care. She’s known for her warmth as well as her brilliance, and we’re thrilled to welcome her to the SGF medical team,” remarked Mark Segal, Chief Executive Officer of SGF.

“I’m thrilled with the opportunity to join SGF. Everything we do is based on what’s best for the patient, and that aligns exactly with my patient care philosophy. We believe in transparency, professionalism, and good communication. I’m here to listen, understand, and help my patients overcome the obstacles in front of them by formulating a game plan that helps them regain control over their struggle,” adds Dr. Brauer.

“I chose this particular field of study, in part, because optimism is the key ingredient to success. This field allows me to mix my love of medicine and surgery. Most importantly, my position allows me to help people build the most sought treasure on earth—a family,” adds Brauer.

“I really felt that Dr. Brauer was personally invested in getting me pregnant. She hugged me before the retrieval and again after the positive pregnancy test. She shared details of her own story that put me at ease and allayed my fears. We had a very straight forward and successful IVF, but her upbeat attitude told me that even if we had a setback she’d have a plan b and another path to success,” shared a recent Dr. Brauer patient.

“New York City is an area that’s actually been underserved when it comes to quality, affordable fertility treatment. By offering SGF’s exclusive 100% refund program for IVF and donor egg in NY—which guarantees patients will take home a baby or receive their money back—individuals and couples no longer have to weigh risk versus benefit when trying to start a family. We believe cost should not be a barrier to seeking help from a fertility specialist,” adds Segal.

Dr. Brauer is accepting new patient appointments in SGF’s brand new 15,300 square foot space in New York City, conveniently located at 110 East 60th Street—minutes from nine NY subway stations with easy access from all boroughs as well as Westchester, Long Island, and Connecticut, and steps from Bloomingdales, Rockefeller Center, Central Park, and The Plaza Hotel.

To make an appointment with Dr. Brauer, call 212-203-4826 or submit this brief form.

To schedule an appointment at any of SGF’s other 35 domestic locations, call the SGF New Patient Center at 888-761-1967.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 36 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

Industry: Healthcare

VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences

Leave a comment


News Image

Together, we are able to safely deliver and monitor our therapies for patients in the comfort of their homes. What this means for the world of cell therapy is nothing short of groundbreaking!


SCOTTSDALE, Ariz. (PRWEB)

VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC’s) for the treatment of spinal cord injury/disorder (SCI/D). Study protocol incorporates remote visits via VirTrial’s telehealth platform.

“After reviewing countless vendors, we found that VirTrial met our needs as a sponsor and most importantly, patient needs. VirTrial’s partnership in our trial has opened doors for patients who would otherwise be unable to participate due to health and lack of mobility,” stated Donna Chang, President and CEO of Hope Biosciences. “Together, we are able to safely deliver and monitor our therapies for patients in the comfort of their homes. What this means for the world of cell therapy is nothing short of groundbreaking!”

A hybrid decentralized clinical trial eliminates barriers to participation for SCI/D patients who have limited access to travel or suffer from the physical toll travel takes on them. Remote visits limit the demand for all visits to be done in-person. At each remote visit, a registered nurse visits the patient in their home and in conjunction with the physician, who is connected via the telehealth platform, conducts a physical exam. Once the physician gives the approval, the RN can administer the stem cell infusion to the patient in their home.

Mark Hanley, CEO of VirTrial, stated, “VirTrial’s telehealth platform reduces the burden associated with patient participation and makes it possible to recruit patients from a larger geographic area. I applaud progressive sponsors like Hope Biosciences who are embracing virtual trial technology to better serve the patient population and advance the clinical trials industry as a whole.”

Sherry Diers, RN, Clinical Affairs Specialist, Hope Biosciences commented, “The logistics and the physical toll for patients can be substantial. Using the VirTrial platform makes it possible for Hope to reach across hundreds of miles and deliver treatment.”

For more information on VirTrial’s offerings for pharmaceutical sponsors, go to https://virtrial.com/pharmaceuticals

About VirTrial

VirTrial is a technology company using a stable, long-standing telehealth platform to transform the clinical trials industry. The platform offers a Virtual Care Management (VCM) program that combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric trials by replacing some study visits with virtual visits. The vision is for 25-50% of the visits to be conducted virtually creating a hybrid model. This model is ideally suited for Phase III/Phase IV trials where patient compliance can be assessed from any location. Our Virtual Care Management (VCM) program allows sites to review and assess patient compliance. The VirTrial app is supported on any device (Apple, Android, tablet and/or computer) and can be used by any site. It is hosted in a secure, cloud-based, environment and is HIPAA compliant.

VirTrial enables greater accessibility to trials for patients, higher performance by clinical trial sites, and improved outcomes for pharmaceutical companies. Working together we can bring better medications to market more quickly. To learn more about VirTrial, visit https://www.virtrial.com

About Hope Biosciences

Hope Biosciences is a clinical stage biotechnology company focused on developing novel cell-based therapeutics for acute and chronic injury and disease. Hope Bio’s core technology lies in stem cell culture and banking. Mesenchymal stem cells are isolated from approximately one tablespoon of a patient’s own fat tissue, purified, and cultured with Hope Bio’s proprietary culture media, HB-101. HB-adMSCs are expanded to multiple passages and released at Passage 4 for therapeutic use. Samples of each passage are banked in order to create a master cell bank for each patient, which will be used to make additional therapies in the future. HB-adMSCs have already been used as a safe and effective treatment in a Phase I/IIa clinical trial for Rheumatoid Arthritis and Individual Expanded Access IND for Parkinson’s disease, Cerebral Palsy, Spinal Cord Injury and Thrombotic Thrombocytopenic Purpura. To learn more about HOPE Biosciences, visit https://www.hope.bio

Share article on social media or email:

Business: Executives

Damon Griggs to Lead Dovel Technologies as CEO

Leave a comment



MCLEAN, Va. (PRWEB)

Dovel Technologies, a leading expert to federal agencies that blends deep domain expertise and advanced technologies in the health IT, life sciences, and grants management markets, today announced that President and Chief Operating Officer Damon Griggs will become Chief Executive Officer of the company effective November 1, 2019. As part of this long-planned succession, current CEO, Paul Leslie, will transition to Executive Chairman of the Board.

Dovel helps advance federal agency missions to bring meaningful change to improve, protect, and save lives. The company has a long, proven history of integrating emerging technologies with domain expertise, mission requirements, and customer needs to produce lasting and highly innovative solutions.

Griggs joined the company in 2016 in the role of COO and assumed the responsibilities of President in 2018. Since Griggs’ arrival, Dovel has more than doubled in size and has built out its infrastructure in preparation for the next phase of growth, including the recent acquisition of Ace Info Solutions. He has been instrumental in the development of Dovel’s corporate strategy, focusing on expanding capabilities, enhancing relationships with current and prospective customers, and providing opportunities for employee growth.

“The Dovel team takes enormous pride in the design, development, and delivery of innovative solutions that fundamentally enable our customers to meet their mission. I am dedicated to continuing to foster a culture of innovation, remaining committed in our customer centricity, while elevating our position as an employer of choice,” said Griggs. “With our ongoing development and expansion of competencies and capabilities, as well as access to a wide-range of contract vehicles, Dovel will continue to provide cutting-edge solutions and expand our reach to broaden our impact across the federal government.”

Leslie joined Dovel as CEO in 2011. In that time, he led the growth of the company from a small business with less than 50 employees into a significant player in the federal government space with over 2,200 personnel today. With Leslie’s vision and leadership, Dovel focused on the health IT, life sciences, and grants management markets, building a unique team by combining subject matter experts to support the technologists, creating solutions for clients working in these complex and data-rich environments.

“I am so grateful to Damon for the outstanding support and exceptional leadership he has provided me and the Dovel team. Succession planning has been a critical component of our strategy as we looked to the future, including the timing of this transition,” commented Leslie. “I have tremendous confidence in Damon and the executive team and look forward to this next chapter in Dovel’s evolution as we continue to expand our capabilities to help our customers create the government of the future.”

About Dovel Technologies

Dovel Technologies blends deep domain expertise with advanced technologies to accelerate solutions that best fit the needs of our customers. We apply deep subject matter experience in health IT, life sciences, and grants management to drive innovation and expand customer capabilities. We harness the power of emerging technologies to integrate complex systems and manage information, allowing for rapid decision-making in data-rich environments. In May 2019,    Dovel received a significant capital investment from Macquarie Capital, the corporate advisory, capital markets, and principal investment arm of Macquarie Group. For more information visit http://www.doveltech.com

Contact:

Piper Conrad

piper.conrad@doveltech.com

571-499-3718

Share article on social media or email:

Health

Prominent Cardiologist Dr. Apurva Shah Receives Castle Connolly’s 2019 Top Doctor® Award for the Seventh Consecutive Year

Leave a comment


News Image

It is always an honor to be recognized by my peers. Being included on a list with so many talented physicians as a 2019 Castle Connolly Top Doctor, is quite the compliment. I will continue my commitment to improving the health and well-being of my patients, says Dr. Apurva Shah


ATLANTA (PRWEB)

Dr. Apurva Shah has once again been recognized as a 2019 Castle Connolly Top Doctor. Recipients of this award were nominated by their fellow doctors, and it is a highly selective list. Those who are among the very best in their specialties are chosen for inclusion. Dr. Shah is board-certified in cardiology. Currently, he is a physician at Northside Heart, which is one of North Atlanta’s largest groups providing cardiology services, with multiple locations throughout the area. Practicing primarily out of the Woodstock office, Dr. Shah specializes in cardiovascular diseases and in non-invasive cardiology. He has a particular interest in cardiovascular imaging, including cardiac perfusion studies, echocardiography and cardiac CT. Dr. Apurva Shah is a trusted physician who is dedicated to providing his patients with top-quality medical care. Many of Dr. Shah’s highly-satisfied patients have shared that he is an excellent communicator, attentive and exceptionally knowledgeable in his field.

“It is always an honor to be recognized by my peers. Being included on a list with so many talented physicians as a 2019 Castle Connolly Top Doctor, is quite the compliment. I will continue my commitment to improving the health and well-being of my patients,” says Dr. Apurva Shah

About Castle Connolly and America’s Top Doctors ®

The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. The top doctors who are listed on their books and website directory were nominated by peers in an extensive survey process of thousands of American doctors each year. These Top Doctors’ medical educations, training, hospital appointments and disciplinary histories are rigorously screened by the Castle Connolly physician-led research team. Doctors do not and cannot pay to be included in any Castle Connolly Guide or online directory.

More about Dr. Apurva Shah

Dr. Shah has been practicing medicine for the past twenty years. He completed his medical school training at the Chicago Medical School and his internal medicine residency at Thomas Jefferson University Hospital in Philadelphia, PA. His cardiology fellowship was performed at the University of Medicine and Dentistry/Robert Wood Johnson Medical School of New Jersey. During that training, he also spent time at the Deborah Heart and Lung Transplant Center. He has been practicing medicine in the Atlanta, Georgia area since 2005.

To schedule an appointment or learn more about Dr. Apurva Shah and Northside Heart please call 770-924-5095 or visit http://www.northsideheart.com/physician/apurva-shah. His Top Doctor profile may also be reviewed on http://www.castleconnolly.com.

Share article on social media or email:

Industry: Healthcare

RealTime Software Solutions Announces They Have Joined SCRS Global Impact Partner Program

Leave a comment


The GIP program gives us the opportunity to listen and contribute on a whole new level


SAN ANTONIO (PRWEB)

As a dedicated leader in the clinical trial industry, RealTime Software Solutions is pleased to announce that they have joined the Society for Clinical Research Sites Global Impact Partner (GIP) Program.

RealTime CEO Rick Greenfield, a long-time member of SCRS, says the partnership is just another way for the company to come together with industry leaders to help streamline the way research is done.

“As a long-time attendee of the Site Solutions Summit and proud member of SCRS, I have seen first-hand the difference that SCRS has made for clinical research sites and the research industry as a whole,” says Greenfield. “I could not be prouder to bring RealTime into the GIP family at SCRS and to join the cause for better processes, systems and best practices that will improve the clinical research landscape for Sites, CROs and Sponsors alike. At RealTime, we prioritize the needs of the industry so we can offer solutions that truly make a difference. The GIP program gives us the opportunity to listen and contribute on a whole new level.”

As a member of GIP, RealTime will have the opportunity to work directly with major players in all facets of the clinical research industry to include large-scale CROs, data vendors, service providers, sites and site networks that all have a hand in shaping clinical research.

Members also benefit by having a seat on the GIP board which interfaces with SCRS leadership to set strategic initiatives for the Society. SCRS GIP members may also elect to engage the SCRS community for individual corporate objectives using SCRS program options that include focus groups, surveys, research, content development, and geographic or regional site support.

To learn more about RealTime Software Solutions, visit RealTime-CTMS.com.

About RealTime Software Solutions

Founded in February of 2013, RealTime Software Solutions, LLC strives to bring innovative Clinical Trial Management Systems (CTMS) to sites, CROs and sponsors of all shapes and sizes. The core values of RealTime include, “Innovation Now”, “Think Like Customers” and “Integrity Always”. These values have helped RealTime grow into a leading CTMS provider for systems like SitePAY, GlobalPAY, eDOCS and eSOURCE for thousands of customers around the world. RealTime will continue the pursuit of advanced systems and processes that enhance the workflow and efficiency of all stakeholders within the clinical research execution process. Visit RealTime-CTMS.com to learn more.

Share article on social media or email:

Business: Executives

LeaseAccelerator’s Michael Keeler Named to the 2019 Washingtonian Magazine Tech Titans List

Leave a comment


“I am honored to be named to the 2019 Washingtonian Magazine Tech Titan List and join a peer group that consists of many of the Washington DC area’s most successful, high-growth companies,” said Michael Keeler, CEO of LeaseAccelerator.


RESTON, Va. (PRWEB)

Michael Keeler, the CEO and Founder of LeaseAccelerator and pioneer in the Enterprise Lease Accounting software market, has been named to the Washingtonian Magazine Tech Titans 2019 List as an Entrepreneur Honoree. The annual list published by Washingtonian Magazine identifies the most important and innovative people in Washington’s digital economy. The award ceremony is scheduled to take place on Tuesday, October 29th, 2019 from 6 p.m. to 9 p.m at the 12 Stories lounge in Washington D.C.

Michael Keeler founded LeaseAccelerator in 2003 as the first enterprise application software company focused on automating the business processes for managing global corporate leasing processes. Over the past few years, Keeler has led LeaseAccelerator through a period of explosive growth which included a $30M growth equity funding from Insight Partners, which fueled LeaseAccelerator’s recent expansion in Europe and Asia Pacific.

With over $3 trillion in spend worldwide, leasing is one of the last major business processes yet to be significantly disrupted by technology. Since its inception LeaseAccelerator’s mission has been to help businesses of all sizes automate the sourcing, management, and accounting of their real estate and equipment lease portfolios. New accounting standards introduced in 2016 have significantly compounded the challenges as businesses must now track the rent and contract terms of each and every leased asset to provide accurate reporting to their shareholders. Even small companies are struggling as they find that spreadsheets and low-budget leasing applications are not adequate to comply with these new rules.

“I am honored to be named to the 2019 Washingtonian Magazine Tech Titan List and join a peer group that consists of many of the Washington DC area’s most successful, high-growth companies,” said Michael Keeler, CEO of LeaseAccelerator. “The entire LeaseAccelerator team should be recognized for our achievements in developing this new category of Enterprise Lease Accounting software. It took hundreds of incremental innovations by the many wonderful entrepreneurs in our company to take such a complex business process as lease accounting and make it so simple and fast for our customers,” noted Keeler.

To read the full profile of Michael Keeler visit the Washingtonian Magazine website at: https://www.washingtonian.com/2019/10/03/tech-titans-2019-washingtons-top-tech-leaders/#The-Entrepreneurs

About LeaseAccelerator:

LeaseAccelerator offers the market-leading SaaS solution for Enterprise Lease Accounting, enabling compliance with the new ASC 842, IFRS 16 and GASB 87 standards. Using LeaseAccelerator’s proprietary Global Lease Accounting Engine, customers can apply the new standards to all categories of leases including real estate, fleet, IT and other equipment at an asset-level. LeaseAccelerator’s Real Estate, Lease Sourcing, and Lease Management applications generate considerable savings through smarter procurement and easier management. Learn more at: http://www.leaseaccelerator.com/.

Share article on social media or email:

Health

ImPACT Applications Successfully Meets Standards of the Medical Device Single Audit Program (MDSAP)

Leave a comment


“Passing the MDSAP is a major accomplishment and yet another example of ImPACT Applications, Inc.’s commitment to quality and compliance.”


SAN DIEGO (PRWEB)

ImPACT Applications successfully passes the intensive Medical Device Single Audit Program (MDSAP) and obtains ISO 13485 re-certification. The audit requires full transparency with the quality management system structure, corrective action and preventive action, software development lifecycle, and IT infrastructure to ensure the public’s security and privacy.

“Choosing to participate in the MDSAP wasn’t a question for us,” said Michael Zagorski, ImPACT Applications’ Director of Regulatory Affairs and Privacy Officer. “Everything from our company procedures to staff training and privacy practices is geared towards making products people can trust.”

MDSAP was created with the goal to unify medical device audit standards to improve their safety and oversight on a global scale. As a worldwide leader in concussion management software, ImPACT Applications is well-equipped to address evolving regulatory agencies’ standards.

Along with being regulatory compliant, ImPACT Applications’ products have over 500 plus research articles (https://concussionresearch.com/) containing independent and peer-reviewed studies that help healthcare providers validate the use of their concussion assessment tools.

“Passing the MDSAP is a major accomplishment and yet another example of ImPACT Applications, Inc.’s commitment to quality and compliance,” said Michael Wahlster, ImPACT Applications’ Chief Executive Officer. “This multi-country audit is necessary for an industry that sees rapid innovation and will help ensure medical device companies prioritize public safety.”

About ImPACT Applications:

ImPACT Applications, Inc. is the maker of ImPACT®, ImPACT Pediatric®, and ImPACT Quick Test®, all FDA cleared Class I & II medical devices that assist in the assessment and management of concussion. ImPACT Applications also offers the FDA cleared ImPACT Baseline Test to home-based users worldwide.

ImPACT Applications products are used by most major medical centers, professional sports leagues and teams, colleges, high schools, and select military units. Since 2002, ImPACT Applications has administered more than 18 million tests to over 11 million users. For more information, visit https://impacttest.com/.

Share article on social media or email: